Knut T Smerud

3PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 15, 2026
Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.

|Feb 27, 2026
A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients.

Roy H Larsen, Arne Kolstad, Alexander Fosså

|Oct 04, 2017
A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate.

Knut T Smerud, Anders Åsberg, Håkon Kile

Pageof 1

Frequent Collaborators

1 joint publications

Timothy Illidge

1 joint publications

Øyvind S Bruland

1 joint publications

Irini Ktoridou-Valen

1 joint publications

Sturla Magnus Grøndal